about
Immutep Ltd is a Phase three clinical biotechnology company developing novel Lymphocyte Activation Gene-3 (LAG-3) related immunotherapies for cancer and autoimmune disease. It has a diversified product portfolio that harnesses LAG-3's ability to stim...
Read More
0.42
-0.02
(-4.55%)
153.6K
XNAS Volume
XNAS 17 Jul, 2026 12:24 PM (EDT)
Not Eligible
Expensive Valuation
Technically Bearish
Immutep Ltd (ADR) Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..